Newron Pharmaceuticals Market Cap

Newron Pharmaceuticals has a market cap or net worth of €219.12 million as of February 21, 2025. Its market cap has increased by 27.13% in one year.

Market Cap

219.12M

Enterprise Value

256.68M

Revenue

6.97M

Ranking

n/a

PE Ratio

n/a

Stock Price

€10.98

Market Cap Chart

Since December 12, 2006, Newron Pharmaceuticals's market cap has increased from 194.15M to 219.12M, an increase of 12.86%. That is a compound annual growth rate of 0.67%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	219.12M	18.41%
Dec 30, 2024	185.06M	94.99%
Dec 29, 2023	94.91M	239.07%
Dec 30, 2022	27.99M	0.21%
Dec 30, 2021	27.93M	-20.96%
Dec 30, 2020	35.34M	-66.13%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Siemens Healthineers AG	62.39B
Merck KGaA	58.91B
Bayer Aktiengesellschaft	21.66B
Fresenius SE & Co. KGaA	20.55B
Sartorius Aktiengesellschaft	15.02B
Fresenius Medical Care AG	12.98B
Carl Zeiss Meditec AG	4.78B
SCHOTT Pharma AG & Co. KGaA	3.57B

Market Cap Rankings